These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 25472652)

  • 21. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
    Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
    Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
    Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
    Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.
    Wierzbicki PM; Adrych K; Kartanowicz D; Stanislawowski M; Kowalczyk A; Godlewski J; Skwierz-Bogdanska I; Celinski K; Gach T; Kulig J; Korybalski B; Kmiec Z
    World J Gastroenterol; 2013 Jul; 19(27):4363-73. PubMed ID: 23885148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
    Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
    Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
    Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
    Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
    Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.
    Ak S; Tunca B; Yilmazlar T; Tezcan G; Cecener G; Egeli U; Ozturk E; Yerci O; Ertürk E; Zorluoglu A
    J Surg Res; 2013 Dec; 185(2):626-37. PubMed ID: 23992855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients.
    Savio AJ; Daftary D; Dicks E; Buchanan DD; Parfrey PS; Young JP; Weisenberger D; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    BMC Cancer; 2016 Feb; 16():113. PubMed ID: 26884349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability.
    Song M; Nishihara R; Wu K; Qian ZR; Kim SA; Sukawa Y; Mima K; Inamura K; Masuda A; Yang J; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25810492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.